Table 2 Univariate and multivariate... | American Society of Hematology

Table 2

Univariate and multivariate analyses for specific hazard of relapse in patients with t(8;21) AML

		Univariate analysis			Multivariate analysis
	Patients	SHR	95% CI	P value	SHR	95% CI	P value
Age*	106	1.00	0.97-1.03	.938	—	—	—
LogWBC*	106	2.47	1.18-5.19	.017†	1.94	0.89-4.27	.097
TK^mut and (chromatin modifiers^WT and cohesin^WT)	31/106	3.88	1.20-12.54	.023†	3.96	1.22-12.91	.022†
TK^mut and (chromatin modifiers^mut and/or cohesin^mut)	38/106	6.21	2.11-18.26	.001†	5.44	1.82-16.27	.002†

		Univariate analysis			Multivariate analysis
	Patients	SHR	95% CI	P value	SHR	95% CI	P value
Age*	106	1.00	0.97-1.03	.938	—	—	—
LogWBC*	106	2.47	1.18-5.19	.017†	1.94	0.89-4.27	.097
TK^mut and (chromatin modifiers^WT and cohesin^WT)	31/106	3.88	1.20-12.54	.023†	3.96	1.22-12.91	.022†
TK^mut and (chromatin modifiers^mut and/or cohesin^mut)	38/106	6.21	2.11-18.26	.001†	5.44	1.82-16.27	.002†

Tested as continuous variable.

P < .05.